Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial

Authors

Institutions

Publication Details

Journal
Circulation
Published
2025-09-10
DOI
https://doi.org/10.1161/circulationaha.125.075080
Citations
7
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
14.04

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial

Brad J. Martinsen, D. Chris Metzger, David O’Connor, Brian G. DeRubertis et al.
7 citations
Circulation
Peripheral Artery Disease Management
14.04
article

Drug-Eluting Resorbable Scaffold Versus Balloon Angioplasty for Below-the-Knee Peripheral Artery Disease: 2-Year Results From the LIFE-BTK Trial

Brad J. Martinsen, D. Chris Metzger, David O’Connor, Brian G. DeRubertis, Osamu Iida, Steven Kum, Jen‐Kuang Lee, Karine Ruster, Sahil A. Parikh, Mehdi H. Shishehbor, Raghu Kolluri, Danielle Bajakian, Ehrin J. Armstrong, Prakash Krishnan, Andrew Holden, Richard H. Pin, Zsuzsanna Igyarto, Marc P. Bonaca, Ramon L. Varcoe, Shawn Yu, Lawrence A. Garcia
article en
7 citations

Abstract

No abstract available for this paper.
CirculationVol. 152(15)
OhioHealth (US), Hackensack University Medical Center (US), NewYork–Presbyterian Hospital (US), Applied Materials (United States) (US), Cornell University (US), University Hospitals of Cleveland (US), Columbia University Irving Medical Center (US), Auckland City Hospital (NZ), Changi General Hospital (SG), Abbott (United Kingdom) (GB), St. Francis Hospital (US), Presbyterian Hospital (US), Mount Sinai Hospital (US), Mount Sinai Hospital (US), Prince of Wales Hospital (AU), Charlton Memorial Hospital (US), Osaka Hospital (JP), Ballad Health (US), National Taiwan University Hospital (TW), Abbott Fund (US), Advanced Engineering (Czechia) (CZ), University of Colorado Denver (US)
Abbott Laboratories, Amgen, Bristol-Myers Squibb, Pfizer, AstraZeneca, Sanofi, Alexion Pharmaceuticals, Alnylam Pharmaceuticals, Osiris Therapeutics, Array BioPharma, CSL Behring, Boston Scientific Corporation, Stryker, Regeneron Pharmaceuticals, Cook Medical, Ionis Pharmaceuticals, Reva Medical, Prothena, Audentes Therapeutics, Kowa Company, Boston Scientific Japan, Agios Pharmaceuticals, VIVA Foundation for Children with Cancer, Abiomed, Insmed, Novo Nordisk, Silence Therapeutics, Esperion Therapeutics, Abbott Vascular, Medtronic Japan, Daiichi Sankyo Europe
Openalex Percentile: Top 1%
Peripheral Artery Disease Management
14.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.